Cyon Therapeutics Inc. is a clinical phase biotechnology company with the goal to address the unmet medical need of severe infection and prevention of sepsis.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free